Cabelando, Agape .
HRN: 26-09-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/29/2024
11/05/2024
IV
400mg
IV
R/O Appendicitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes